GILD vs IPW · P/E 18, rev $7.80B vs rev $66.1M
Gilead Sciences Inc (GILD) versus iPower Inc (IPW) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
iPower Inc (IPW) is a internet retail company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported IPW revenue for 2025-06-30 was $66.1M. IPW currently screens at market cap $20.1M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. IPW currently screens at market cap $20.1M.
Not investment advice. Open the GILD and IPW stock pages for the full models.
Not investment advice.